Ampyra Warnings
Feb 21, 2014 4:37:32 GMT -8
Post by bob on Feb 21, 2014 4:37:32 GMT -8
The FDA first approved Ampyra in January 2010. But a report from the fourth quarter of that year by the Institute for Safe Medication Practices (ISMP) (pdf) found 217 adverse event reports sent in to the FDA in that three month period which included reports that Ampyra actually decreased walking speed. - See more at: www.aboutlawsuits.com/ampyra-seizure-warning-2-30882/#sthash.sGhr99Xn.dpuf
So why is it still on the market? Corruption?
Unaudited AMPYRA® (dalfampridine) 2013 Fourth Quarter Net Sales of $84 Million and Unaudited 2013 Full-Year Net Sales of $302 Million
